Bookmark
Print
Send to a friend
Age-related Macular Degeneration (AMD)
Ocular allergy
Ocular angiogenesis
Capillary nonperfusion
Cataract
Contactology
Corneal wound healing
Diabetic retinopathy
Diabetic macular edema
Dry eye syndrome
Eye edema
Glaucoma
Ocular infection
Ocular inflammation
Keratoconjunctivitis sicca
Medical devices
Ocular neovascularization
Ocular neurodegeneration
Orphan diseases
Ocular pain
Retinal ischemia
Retinal vein occlusion
Retinitis pigmentosa
Ocular rosacea
Ocular surgery
Trachoma
Uveitis
Visual defects
Home » About us » Overview » Introduction
Iris Pharma, the specialist CRO in preclinical and clinical research in ophthalmology

WHO ARE WE ?

Iris Pharma is a world leading, Contract Research Organization (CRO) specializing in global drug development in ophthalmology. Founded in 1989, Iris Pharma is a privately held service company which offers its services to pharmaceutical and biotechnology companies of all sizes and of all levels of experience, from newcomers to experts in ophthalmology.

OUR EXPERTISE

Iris Pharma’s strength is the combination of our highly skilled staff and our specific focus on ophthalmology. We have gained a unique expertise and know-how in our specialist field that guarantees our clients high quality and accurate services at every stage of ocular drug development.

Since 1989 we have been successfully offering ophthalmologic drug and device development services to more than 200 international customers. Our highly qualified and experienced staff have performed some 2,000 preclinical ocular studies and nearly 90 clinical ocular trials with the same objective: to deliver professional quality work to help our customers to develop the potential of their ophthalmologic drugs.

OUR SERVICES

We can support ophthalmology preclinical and clinical research projects with a wide range of specialized services in the following complementary areas:

QUALITY

At Iris Pharma, quality is a state of mind. Our Quality Assurance program is designed to ensure that your studies are performed in compliance with GLP and ICH-GCP requirements, guidelines (including FDA and OECD) and local regulatory laws. Inspections, as well as planned and unscheduled audits are regularly performed and we are certified by the French regulatory authorities (ANSM - formerly AFSSAPS).